News
Mounjaro weight-loss drug price to almost triple in UK after Trump complaint - At least 500,000 people in the UK take either ...
Republican leaders pushed back on the DHHS approach. They also tied the dispute to broader state budget negotiations.
An increasing popular class of drugs is a big driver of the expected higher costs. A class-action lawsuit is a warning shot ...
By Nqobile Dludla and Siyanda Mthethwa JOHANNESBURG (Reuters) -Danish drugmaker Novo Nordisk introduced its weight-loss drug ...
Eli Lilly will increase the UK price of its Mounjaro treatment by 170% to match European markets. Despite Novo Nordisk's ...
Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa ...
Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.
A sweeping analysis of global studies reveals that stopping weight loss drugs, including well-known treatments like Ozempic and Wegovy, often triggers a rapid return of lost pounds.
One study found a modest risk of developing non-arteritic anterior ischaemic optic neuropathy (NAOIN), a rare eye condition ...
There is zero evidence that semaglutides can increase the size of your crown jewels. What may happen is that as you lose ...
Novo Nordisk (NYSE: NVO) is quite the divisive stock among both investors and analysts these days. Although its high-profile ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results